Literature DB >> 33940636

Lepto mets: loads of data.

Larry Junck1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33940636      PMCID： PMC8248839          DOI： 10.1093/neuonc/noab089

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours.

Authors:  E Le Rhun; M Weller; D Brandsma; M Van den Bent; E de Azambuja; R Henriksson; T Boulanger; S Peters; C Watts; W Wick; P Wesseling; R Rudà; M Preusser
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

Review 2.  Leptomeningeal metastases: a RANO proposal for response criteria.

Authors:  Marc Chamberlain; Larry Junck; Dieta Brandsma; Riccardo Soffietti; Roberta Rudà; Jeffrey Raizer; Willem Boogerd; Sophie Taillibert; Morris D Groves; Emilie Le Rhun; Julie Walker; Martin van den Bent; Patrick Y Wen; Kurt A Jaeckle
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

3.  Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience.

Authors:  Nicholas B Figura; Wendy Long; Michael Yu; Timothy J Robinson; Sepideh Mokhtari; Arnold B Etame; Nam D Tran; Roberto Diaz; Hatem Soliman; Heather S Han; Solmaz Sahebjam; Peter A Forsyth; Kamran A Ahmed
Journal:  Breast Cancer Res Treat       Date:  2018-02-01       Impact factor: 4.872

4.  Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion.

Authors:  R G Blasberg; C Patlak; J D Fenstermacher
Journal:  J Pharmacol Exp Ther       Date:  1975-10       Impact factor: 4.030

5.  Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.

Authors:  W R Shapiro; D F Young; B M Mehta
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

6.  Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study.

Authors:  James C H Yang; Sang-We Kim; Dong-Wan Kim; Jong-Seok Lee; Byoung Chul Cho; Jin-Seok Ahn; Dae H Lee; Tae Min Kim; Jonathan W Goldman; Ronald B Natale; Andrew P Brown; Barbara Collins; Juliann Chmielecki; Karthick Vishwanathan; Ariadna Mendoza-Naranjo; Myung-Ju Ahn
Journal:  J Clin Oncol       Date:  2019-12-06       Impact factor: 44.544

7.  Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors.

Authors:  Emilie Le Rhun; Patrick Devos; Johannes Weller; Katharina Seystahl; Francesca Mo; Annette Compter; Anna S Berghoff; Joost L M Jongen; Fabian Wolpert; Roberta Rudà; Dieta Brandsma; Martin van den Bent; Matthias Preusser; Ulrich Herrlinger; Michael Weller
Journal:  Neuro Oncol       Date:  2021-07-01       Impact factor: 12.300
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.